http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03112838-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b98749d7acee2c4ed32683c81243ddfd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C04B12-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K6-838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B25-32
filingDate 1989-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeccecfd63bb97191ec4d5f4c3ae78db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8235660f48ead7230253f6f1a51ba90f
publicationDate 1991-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03112838-A
titleOfInvention Wet-process for producing alpha-type calcium triphosphate cement
abstract PURPOSE: To obtain a cement easily curable by hydration, having high uniformity and giving a cured product having high compressive strength by reacting a suspension of calcium hydroxide with an aqueous solution of phosphoric acid at a specific temperature and a specific final concentration of the reaction product and calcining the product. n CONSTITUTION: A calcium phosphate cement is produced by wet-process comprising the reaction of a suspension of calcium hydroxide and an aqueous solution of phosphoric acid and the calcination of the resultant precipitate of calcium phosphate. The process is carried out as follows. A suspension of calcium hydroxide is made to react with an aqueous solution of phosphoric acid at 50-100°C under a condition to give a final reaction product concentration of 5-25%. The obtained mixture of hydroxyapatite and calcium diphosphate is calcined to obtain the objective α-type calcium triphosphate cement. The cement gives a hydrated and cured product having extremely high compressive strength exceeding that of a dry-process cement obtained by the re-calcination under pressure. n COPYRIGHT: (C)1991,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5268032-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0749400-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5885540-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5683667-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0705802-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5709742-A
priorityDate 1989-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452135712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9874960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447730362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450102629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452333222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093208

Total number of triples: 30.